179 related articles for article (PubMed ID: 29020023)
1. The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.
Lauridsen MM; Mikkelsen S; Svensson T; Holm J; Klüver C; Gram J; Vilstrup H; Schaffalitzky de Muckadell OB
PLoS One; 2017; 12(10):e0185412. PubMed ID: 29020023
[TBL] [Abstract][Full Text] [Related]
2. Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests.
Lauridsen MM; Schaffalitzky de Muckadell OB; Vilstrup H
Metab Brain Dis; 2015 Oct; 30(5):1187-92. PubMed ID: 26016624
[TBL] [Abstract][Full Text] [Related]
3. Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
Wernberg CW; Schaffalitzky de Muckadell OB; Vilstrup H; M Lauridsen M
PLoS One; 2019; 14(12):e0226283. PubMed ID: 31830113
[TBL] [Abstract][Full Text] [Related]
4. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
5. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy.
Lauridsen MM; Poulsen L; Rasmussen CK; Høgild M; Nielsen MK; de Muckadell OB; Vilstrup H
Metab Brain Dis; 2016 Apr; 31(2):267-72. PubMed ID: 26435407
[TBL] [Abstract][Full Text] [Related]
6. Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea.
Jeong JY; Jun DW; Bai D; Kim JY; Sohn JH; Ahn SB; Kim SG; Kim TY; Kim HS; Jeong SW; Cho YK; Song DS; Kim HY; Jung YK; Yoon EL
J Korean Med Sci; 2017 Sep; 32(9):1484-1490. PubMed ID: 28776344
[TBL] [Abstract][Full Text] [Related]
7. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
8. Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.
Li SW; Wang K; Yu YQ; Wang HB; Li YH; Xu JM
World J Gastroenterol; 2013 Dec; 19(46):8745-51. PubMed ID: 24379595
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy.
Montagnese S; Lauridsen M; Vilstrup H; Zarantonello L; Lakner G; Fitilev S; Zupanets I; Kozlova I; Bunkova E; Tomasiewicz K; Berglund JE; Rorsman F; Hagström H; Kechagias S; Ocklind CE; Mauney J; Thunarf F; Mokhatarani M; Bäckström T; Doverskog M; Lins LE; Månsson M; Samuelson P; Nilsson D; Schalling M; Johansson M; Arlander E; Scharschmidt BF
J Hepatol; 2021 Jul; 75(1):98-107. PubMed ID: 33894327
[TBL] [Abstract][Full Text] [Related]
10. Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients.
Wuensch T; Ruether DF; Zöllner C; Mueller T; Jung T; Kaffarnik M; Kassner U; Schott E; Kiefer S; Pratschke J; Stockmann M; Jara M
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):456-463. PubMed ID: 28092641
[TBL] [Abstract][Full Text] [Related]
11. Minimal hepatic encephalopathy in cirrhosis- how long to treat?
Goyal O; Sidhu SS; Kishore H
Ann Hepatol; 2017 Jan-Feb 2017; 16(1):115-122. PubMed ID: 28051800
[TBL] [Abstract][Full Text] [Related]
12. Assessment of low-grade hepatic encephalopathy: a critical analysis.
Kircheis G; Fleig WE; Görtelmeyer R; Grafe S; Häussinger D
J Hepatol; 2007 Nov; 47(5):642-50. PubMed ID: 17869373
[TBL] [Abstract][Full Text] [Related]
13. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial).
Sidhu SS; Goyal O; Mishra BP; Sood A; Chhina RS; Soni RK
Am J Gastroenterol; 2011 Feb; 106(2):307-16. PubMed ID: 21157444
[TBL] [Abstract][Full Text] [Related]
14. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
[TBL] [Abstract][Full Text] [Related]
15. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
[TBL] [Abstract][Full Text] [Related]
16. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
17. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
[TBL] [Abstract][Full Text] [Related]
18. Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy -current validation level and practical use.
Hansen MKG; Kjærgaard K; Eriksen LL; Grønkjær LL; Mikkelsen ACD; Sandahl TD; Vilstrup H; Thomsen KL; Lauridsen MME
Metab Brain Dis; 2022 Mar; 37(3):589-605. PubMed ID: 35102491
[TBL] [Abstract][Full Text] [Related]
19. Management of hepatic encephalopathy in the hospital.
Leise MD; Poterucha JJ; Kamath PS; Kim WR
Mayo Clin Proc; 2014 Feb; 89(2):241-53. PubMed ID: 24411831
[TBL] [Abstract][Full Text] [Related]
20. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
Sidhu SS; Goyal O; Parker RA; Kishore H; Sood A
Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
